Aptose Biosciences's total assets for Q2 2025 were $5.59M, a decrease of -25.12% from the previous quarter. APTOF total liabilities were $19.96M for the fiscal quarter, a 34.33% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.